Myocardial viability and impact of surgical ventricular reconstruction on outcomes of patients with severe left ventricular dysfunction undergoing coronary.

Slides:

Advertisements

Similar presentations

Insights from the STICH trial: Change in left ventricular size after coronary artery bypass grafting with and without surgical ventricular reconstruction

Advertisements

The “occasional open heart surgeon” revisited

Meta-analysis of minimally invasive coronary artery bypass versus drug-eluting stents for isolated left anterior descending coronary artery disease Ralf.

Total arterial revascularization of triple vessel coronary disease based on combined internal thoracic and radial artery grafts Robert H. Habib, PhD,

Manuel J. Antunes, MD, PhD, DSc

Benefits and risks of using clopidogrel before coronary artery bypass surgery: Systematic review and meta-analysis of randomized trials and observational.

Factors associated with postoperative atrial fibrillation and other adverse events after cardiac surgery Emmanuel Akintoye, MD, MPH, Frank Sellke, MD,

Myocardial bridging over the left anterior descending: Myotomy, bypass, or both? Chigozirim N. Ekeke, BS, Stephen Noble, MD, Ernest Mazzaferri, MD, Juan.

Pre-existing psychological depression confers increased risk of adverse cardiovascular outcomes following cardiac surgery: A systematic review and meta-analysis

Off-pump coronary artery bypass grafting does not preserve renal function better than on-pump coronary artery bypass grafting: Results of a case-matched.

The impact of placing multiple grafts to each myocardial territory on long-term survival after coronary artery bypass grafting Danny Chu, MD, Faisal.

Meta-analysis of minimally invasive coronary artery bypass versus drug-eluting stents for isolated left anterior descending coronary artery disease Ralf.

The American Association for Thoracic Surgery 2016 Ethics Forum: Cost-effectiveness and the ethics of left ventricular assist device therapy John W.C.

The persistent problem of new-onset postoperative atrial fibrillation: A single-institution experience over two decades Jeanne Shen, BS, Shelly Lall,

Damien J. LaPar, MD, MSc, Carlos M. Mery, MD, MPH, Benjamin D

Increased late mortality after coronary artery bypass surgery complicated by isolated new-onset atrial fibrillation: A comprehensive propensity-matched.

Pulmonary atresia with intact ventricular septum: Predictors of early and medium-term outcome in a population-based study Piers E.F. Daubeney, MRCP,

Stenting versus coronary artery bypass grafting for unprotected left main coronary artery disease: A meta-analysis of comparative studies Hisato Takagi,

CD133+ cells: How could they have an IMPACT?

Mild-to-moderate functional tricuspid regurgitation in patients undergoing mitral valve surgery Sun Kyun Ro, MD, Joon Bum Kim, MD, Sung Ho Jung, MD,

Insights from the STICH trial: Change in left ventricular size after coronary artery bypass grafting with and without surgical ventricular reconstruction

Clinical significance and determinants of the universal definition of perioperative bleeding classification in patients undergoing coronary artery bypass.

Shikhar Agarwal, MD, MPH, Aatish Garg, MD, Akhil Parashar, MD, Lars G

Which is more important in the potential interference on cardioprotection by remote ischemic preconditioning: β-blockers or anesthetic choice? Yang Liu,

Neurologic complications after off-pump coronary artery bypass grafting with and without aortic manipulation: Meta-analysis of 11,398 cases from 8 studies

Long-Term Survival of Patients With Ischemic Cardiomyopathy Treated by Coronary Artery Bypass Grafting Versus Medical Therapy Eric J. Velazquez, MD,

Juan A. Crestanello, MD, Richard C. Daly, MD

Coronary artery bypass grafting is superior to first-generation drug-eluting stents for unprotected left main coronary artery disease: An updated meta-analysis.

Lower graft patency after off-pump than on-pump coronary artery bypass grafting: An updated meta-analysis of randomized trials Hisato Takagi, MD, PhD,

Defining operative mortality: Impact on outcome reporting

Why surgery won the SYNTAX trial and why it matters

Hisato Takagi, MD, PhD, Takuya Umemoto, MD, PhD

Zhe Zheng, MD, PhD, Heng Zhang, MD, PhD, Bo Xu, MBBS

Coronary artery bypass in patients with type 2 diabetes: Experience from the Bypass Angioplasty Revascularization Investigation 2 Diabetes trial Edward.

Multilevel data analysis: What? Why? How?

Harold L. Lazar, MD The Journal of Thoracic and Cardiovascular Surgery

Predictors of contemporary coronary artery bypass grafting outcomes

The lord of the rings Antonio Miceli, MD, PhD

Impact of prior hospital mortality versus surgical volume on mortality following surgery for congenital heart disease Matthew E. Oster, MD, Matthew J.

Association of hospital coronary artery bypass volume with processes of care, mortality, morbidity, and the Society of Thoracic Surgeons composite quality.

Surgical economics: MACRA, MIPS, and bundles—Lessons learned in the first 3 years of a coronary artery bypass grafting alternative payment model Daniel.

Optimal timing of coronary artery bypass after acute myocardial infarction: A review of California discharge data Eric S. Weiss, MD, David D. Chang,

A decade after the Surgical Treatment for Ischemic Heart Failure (STICH) trial: Weaving firm clinical recommendations from lessons learned Robert E.

The effect of coronary artery bypass grafting on specific causes of long-term mortality in the Bypass Angioplasty Revascularization Investigation David.

Performance of the European System for Cardiac Operative Risk Evaluation II: A meta- analysis of 22 studies involving 145,592 cardiac surgery procedures

For everything there is a season

Myocardial viability and impact of surgical ventricular reconstruction on outcomes of patients with severe left ventricular dysfunction undergoing coronary.

Preoperative prediction of long-term survival after coronary artery bypass grafting in patients with low left ventricular ejection fraction Joseph J.

Chronic obstructive pulmonary disease severity influences outcomes after off-pump coronary artery bypass Benjamin Medalion, MD, Michael G. Katz, MD,

The empire strikes back: Surgical ventricular reconstruction works very well in Japan Lorenzo A. Menicanti, MD The Journal of Thoracic and Cardiovascular.

Nonelective cardiac surgery in the elderly: Is it justified?

Niv Ad, MD, Lawrence M. Wei, MD

Hisato Takagi, MD, PhD, Takuya Umemoto, MD, PhD

Unifocalization of major aortopulmonary collateral arteries in pulmonary atresia with ventricular septal defect is essential to achieve excellent outcomes.

Passing the torch The Journal of Thoracic and Cardiovascular Surgery

Implication of right ventricular dysfunction on long-term outcome in patients with ischemic cardiomyopathy undergoing coronary artery bypass grafting.

Left ventricular assist device implantation after acute anterior wall myocardial infarction and cardiogenic shock: A two-center study Nicholas C. Dang,

Occult renal dysfunction: a mortality and morbidity risk factor in coronary artery bypass grafting surgery Antonio Miceli, MD, Vito D. Bruno, MD, Radek.

Guidance for the use of bilateral internal thoracic arteries according to survival benefit across age groups Umberto Benedetto, MD, PhD, Mohamed Amrani,

Constantine L. Athanasuleas, MD, FACC

The Journal of Thoracic and Cardiovascular Surgery

Discussion The Journal of Thoracic and Cardiovascular Surgery

Ventricular assistant in restrictive cardiomyopathy: Making the right connection Robert D.B. Jaquiss, MD The Journal of Thoracic and Cardiovascular Surgery

Improved quality and cost-effectiveness of coronary artery bypass grafting in the United States from 1988 to 2005 Howard K. Song, MD, PhD, Brian S. Diggs,

Right internal thoracic artery versus radial artery as the second best arterial conduit: Insights from a meta-analysis of propensity-matched data on long-term.

“The more things change…”: The challenges ahead

Appropriate Use Criteria for coronary revascularization in patients with stable ischemic heart disease: What the surgeon needs to know Harold L. Lazar,

Apples remain apples NO matter what

National trends in utilization and in-hospital outcomes of mechanical versus bioprosthetic aortic valve replacements Abby J. Isaacs, MS, Jeffrey Shuhaiber,

Left atrial to left ventricle bypass for mitral valve stenosis

Presentation transcript:

Myocardial viability and impact of surgical ventricular reconstruction on outcomes of patients with severe left ventricular dysfunction undergoing coronary artery bypass surgery: Results of the Surgical Treatment for Ischemic Heart Failure trial Thomas A. Holly, MD, Robert O. Bonow, MD, MS, J. Malcolm O. Arnold, MD, Jae K. Oh, MD, Padmini Varadarajan, MD, Gerald M. Pohost, MD, Haissam Haddad, MD, Robert H. Jones, MD, Eric J. Velazquez, MD, Bozena Birkenfeld, MD, Federico M. Asch, MD, Marcin Malinowski, MD, Rodrigo Barretto, MD, Renato A.K. Kalil, MD, PhD, Daniel S. Berman, MD, Jie-Lena Sun, MS, Kerry L. Lee, PhD, Julio A. Panza, MD The Journal of Thoracic and Cardiovascular Surgery Volume 148, Issue 6, Pages 2677-2684.e1 (December 2014) DOI: 10.1016/j.jtcvs.2014.06.090 Copyright © 2014 The American Association for Thoracic Surgery Terms and Conditions

Figure 1 Kaplan–Meier estimates of the probability of death (A) and death or cardiovascular hospitalization (B) according to myocardial viability status. CI, Confidence interval; HR, hazard ratio. The Journal of Thoracic and Cardiovascular Surgery 2014 148, 2677-2684.e1DOI: (10.1016/j.jtcvs.2014.06.090) Copyright © 2014 The American Association for Thoracic Surgery Terms and Conditions

Figure 2 Kaplan–Meier estimates of the probability of death (A) and death or cardiovascular hospitalization (B) according to myocardial viability status and treatment. CABG, Coronary artery bypass grafting; CI, confidence interval; SVR, surgical ventricular reconstruction. The Journal of Thoracic and Cardiovascular Surgery 2014 148, 2677-2684.e1DOI: (10.1016/j.jtcvs.2014.06.090) Copyright © 2014 The American Association for Thoracic Surgery Terms and Conditions

Figure 3 Kaplan–Meier estimates of the probability of death according to anterior wall myocardial viability status and treatment (A), apical myocardial viability status and treatment (B), and anterior or apical myocardial viability status and treatment (C). CABG, Coronary artery bypass grafting; CI, confidence interval; SVR, surgical ventricular reconstruction. The Journal of Thoracic and Cardiovascular Surgery 2014 148, 2677-2684.e1DOI: (10.1016/j.jtcvs.2014.06.090) Copyright © 2014 The American Association for Thoracic Surgery Terms and Conditions

Figure E1 Five-segment model of the left ventricle used for analysis of regional viability. The Journal of Thoracic and Cardiovascular Surgery 2014 148, 2677-2684.e1DOI: (10.1016/j.jtcvs.2014.06.090) Copyright © 2014 The American Association for Thoracic Surgery Terms and Conditions